Duncan Charles Cliff (CIK 2130896) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy VNDA (41,600 shares), Buy VNDA (57,101 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Vanda Pharmaceuticals Inc. (VNDA) | Director | Buy | 41,600 | $0 |
| 2026-04-24 | Vanda Pharmaceuticals Inc. (VNDA) | Director | Buy | 57,101 | $0 |
Source: SEC Form 4 filings · as of 2026-06-08